ICON Central Laboratories provides global central laboratory services from four global locations

ICON Central Laboratories is headquartered in Farmingdale, New York and provides global central laboratory services from wholly-owned facilities in New York, Dublin, Singapore and China

ICON Central Laboratories maintains a number of industry accreditations and certifications as a means of benchmarking quality and assuring clients of our adherence to industry and regulatory standards. These certifications include: CAP Accreditation, CLIA NY State and NGSP. In addition, ICON Central Laboratories participates in a broad range of proficiency programs to provide continuing assurance of our testing accuracy and rigor.    

As a laboratory dedicated exclusively to the support of clinical trials, we recognise the importance of having standardised testing platforms, instrumentation and testing methodologies in all our facilities.

Dublin, Ireland

Located at the ICON plc headquarters, our Dublin laboratory opened in 1995. The facility offers 41,000 sq ft (3,800m²) of laboratory space, providing centralised testing and site support services to clinical investigators in over 70 countries throughout Europe, Middle East and Africa. New dedicated laboratories have been created to accommodate more specialised testing services in the areas of anatomic pathology, molecular diagnostics and multiplex assays.

Opened: 1995

CAP Accredited: 2003

Farmingdale, New York

Established in 1993, ICON Central Laboratories’ global headquarters is located in Farmingdale, New York and consists of 114,000 square feet.

Opened: 1993

CAP Accredited: 2003

Singapore

Established in 2007 our Singapore facility consists of 8,600 square feet.

Opened: 2007

CAP Accredited: 2009

Beijing, China

The new 950 sqm facility will support global drug development and will also house ICON clinical research and other staff. While ICON Labs has had a presence in China since 2007, this is the first time that the lab will be co-located with other ICON services in Beijing. The lab was previously located in Tianjin.

Opened: 2020

CAP Accredited: 2010